Tumor necrosis factor-α confers cardioprotection through ectopic expression of keratins K8 and K18

Nature Medicine

Volumn 21, Issue 9, 2015, Pages 1076-1084

  Papathanasiou, Stamatis ^a   Rickelt, Steffen ^b,h   Soriano, Maria Eugenia ^c   Schips, Tobias G ^d   Maier, Harald J ^e   Davos, Constantinos H ^a   Varela, Aimilia ^a   Kaklamanis, Loukas ^f   Mann, Douglas L ^g   Capetanaki, Yassemi ^a  

^a BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF PADOVA   (Italy)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e UNIVERSITY OF ULM   (Germany)

^f ONASSIS CARDIAC SURGERY CENTER   (Greece)

^g WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 18; CYTOKERATIN 8; DESMIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERMEDIATE FILAMENT PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; CONTROLLED STUDY; CYTOSKELETON; DESMOSOME; ECTOPIC EXPRESSION; EXPERIMENTAL HEART FAILURE; FEMALE; GENE EXPRESSION; GENETIC MODEL; HEART MUSCLE CELL; HEART PROTECTION; HUMAN; IMMUNOELECTRON MICROSCOPY; IMMUNOFLUORESCENCE MICROSCOPY; MALE; MITOCHONDRIAL RESPIRATION; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; TRANSMISSION ELECTRON MICROSCOPY; UPREGULATION; ANIMAL; C57BL MOUSE; CARDIOMEGALY; PHYSIOLOGY;

ANIMALS; CARDIOMEGALY; DESMIN; FEMALE; HUMANS; KERATIN-18; KERATIN-8; MALE; MICE; MICE, INBRED C57BL; NF-KAPPA B; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84941022388     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.3925     Document Type: Article

References (55)

1. Mann, D.L. Stress-activated cytokines and the heart: from adaptation to maladaptation. Annu. Rev. Physiol. 65, 81-101 (2003).
2. Levine, B., Kalman, J., Mayer, L., Fillit, H.M. & Packer, M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N. Engl. J. Med. 323, 236-241 (1990).
3. Sivasubramanian, N. et al. Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor. Circulation 104, 826-831 (2001).
4. Pagani, F.D. et al. Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-a in conscious dogs. J. Clin. Invest. 90, 389-398 (1992).
5. Omary, M.B., Ku, N.O., Strnad, P. & Hanada, S. Toward unraveling the complexity of simple epithelial keratins in human disease. J. Clin. Invest. 119, 1794-1805 (2009).
6. Pan, X., Hobbs, R.P. & Coulombe, P.A. The expanding significance of keratin intermediate filaments in normal and diseased epithelia. Curr. Opin. Cell Biol. 25, 47-56 (2013).
7. Durán, W.N. The double-edge sword of TNF-a in ischemia-reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 295, H2221-H2222 (2008).
8. Kapadia, S.R. et al. Elevated circulating levels of serum tumor necrosis factor-a in patients with hemodynamically significant pressure and volume overload. J. Am. Coll. Cardiol. 36, 208-212 (2000).
9. Burchfield, J.S. et al. The cytoprotective effects of tumor necrosis factor are conveyed through tumor necrosis factor receptor-associated factor 2 in the heart. Circ Heart Fail 3, 157-164 (2010).
10. Kurrelmeyer, K.M. et al. Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction. Proc. Natl. Acad. Sci. USA 97, 5456-5461 (2000).
11. Feldman, A.M., Kadokami, T., Higuichi, Y., Ramani, R. & McTiernan, C.F. The role of anticytokine therapy in heart failure: recent lessons from preclinical and clinical trials? Med. Clin. North Am. 87, 419-440 (2003).
12. Haudek, S.B., Taffet, G.E., Schneider, M.D. & Mann, D.L. TNF provokes cardiomyocyte apoptosis and cardiac remodeling through activation of multiple cell death pathways. J. Clin. Invest. 117, 2692-2701 (2007).
13. Panagopoulou, P. et al. Desmin mediates TNF-a-induced aggregate formation and intercalated disk reorganization in heart failure. J. Cell Biol. 181, 761-775 (2008).
14. Capetanaki, Y., Papathanasiou, S., Diokmetzidou, A., Vatsellas, G. & Tsikitis, M. Desmin related disease: a matter of cell survival failure. Curr. Opin. Cell Biol. 32, 113-120 (2015).
15. Goldfarb, L.G. & Dalakas, M.C. Tragedy in a heartbeat: malfunctioning desmin causes skeletal and cardiac muscle disease. J. Clin. Invest. 119, 1806-1813 (2009).
16. Milner, D.J., Weitzer, G., Tran, D., Bradley, A. & Capetanaki, Y. Disruption of muscle architecture and myocardial degeneration in mice lacking desmin. J. Cell Biol. 134, 1255-1270 (1996).
17. Psarras, S. et al. Regulation of adverse remodelling by osteopontin in a genetic heart failure model. Eur. Heart J. 33, 1954-1963 (2012).
18. Mavroidis, M. et al. Complement system modulation as a target for treatment of arrhythmogenic cardiomyopathy. Basic Res. Cardiol. 110, 27 (2015).
19. Milner, D.J., Mavroidis, M., Weisleder, N. & Capetanaki, Y. Desmin cytoskeleton linked to muscle mitochondrial distribution and respiratory function. J. Cell Biol. 150, 1283-1298 (2000).
20. Moll, R., Franke, W.W., Schiller, D.L., Geiger, B. & Krepler, R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31, 11-24 (1982).
21. Kuruc, N. & Franke, W.W. Transient coexpression of desmin and cytokeratins 8 and 18 in developing myocardial cells of some vertebrate species. Differentiation 38, 177-193 (1988).
22. Gown, A.M. & Vogel, A.M. Monoclonal antibodies to human intermediate filament proteins. II. Distribution of filament proteins in normal human tissues. Am. J. Pathol. 114, 309-321 (1984).
23. Ursitti, J.A. et al. Cloning and characterization of cytokeratins 8 and 19 in adult rat striated muscle. Interaction with the dystrophin glycoprotein complex. J. Biol. Chem. 279, 41830-41838 (2004).
24. Maier, H.J. et al. Cardiomyocyte-specific I-B kinase (IKK)/NF-B activation induces reversible inflammatory cardiomyopathy and heart failure. Proc. Natl. Acad. Sci. USA 109, 11794-11799 (2012).
25. Brown, M. et al. Cardiac-specific blockade of NF-B in cardiac pathophysiology: differences between acute and chronic stimuli in vivo. Am. J. Physiol. Heart Circ. Physiol. 289, H466-H476 (2005).
26. Franke, W.W., Borrmann, C.M., Grund, C. & Pieperhoff, S. The area composita of adhering junctions connecting heart muscle cells of vertebrates. I. Molecular definition in intercalated disks of cardiomyocytes by immunoelectron microscopy of desmosomal proteins. Eur. J. Cell Biol. 85, 69-82 (2006).
27. Kim, S. & Coulombe, P.A. Intermediate filament scaffolds fulfill mechanical, organizational, and signaling functions in the cytoplasm. Genes Dev. 21, 1581-1597 (2007).
28. Magin, T.M. et al. Lessons from keratin 18 knockout mice: formation of novel keratin filaments, secondary loss of keratin 7 and accumulation of liver-specific keratin 8-positive aggregates. J. Cell Biol. 140, 1441-1451 (1998).
29. Tao, G.Z. et al. Keratins modulate the shape and function of hepatocyte mitochondria: a mechanism for protection from apoptosis. J. Cell Sci. 122, 3851-3855 (2009).
30. Loranger, A., Gilbert, S., Brouard, J.S., Magin, T.M. & Marceau, N. Keratin 8 modulation of desmoplakin deposition at desmosomes in hepatocytes. Exp. Cell Res. 312, 4108-4119 (2006).
31. Kröger, C. et al. Keratins control intercellular adhesion involving PKC-a-mediated desmoplakin phosphorylation. J. Cell Biol. 201, 681-692 (2013).
32. Green, K.J. & Gaudry, C.A. Are desmosomes more than tethers for intermediate filaments? Nat. Rev. Mol. Cell Biol. 1, 208-216 (2000).
33. Capetanaki, Y. Desmin cytoskeleton: a potential regulator of muscle mitochondrial behavior and function. Trends Cardiovasc. Med. 12, 339-348 (2002).
34. Toivola, D.M., Tao, G.Z., Habtezion, A., Liao, J. & Omary, M.B. Cellular integrity plus: organelle-related and protein-targeting functions of intermediate filaments. Trends Cell Biol. 15, 608-617 (2005).
35. Fountoulakis, M. et al. Alterations in the heart mitochondrial proteome in a desmin null heart failure model. J. Mol. Cell. Cardiol. 38, 461-474 (2005).
36. Duan, S. et al. The Pirh2-keratin 8/18 interaction modulates the cellular distribution of mitochondria and UV-induced apoptosis. Cell Death Differ. 16, 826-837 (2009).
37. Stone, M.R. et al. Absence of keratin 19 in mice causes skeletal myopathy with mitochondrial and sarcolemmal reorganization. J. Cell Sci. 120, 3999-4008 (2007).
38. Molkentin, J.D. et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93, 215-228 (1998).
39. Arber, S. et al. MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure. Cell 88, 393-403 (1997).
40. Kaplan, S.R. et al. Structural and molecular pathology of the heart in Carvajal syndrome. Cardiovasc. Pathol. 13, 26-32 (2004).
41. Li, X. et al. Cardiac-specific overexpression of tumor necrosis factor-a causes oxidative stress and contractile dysfunction in mouse diaphragm. Circulation 102, 1690-1696 (2000).
42. Huss, J.M. et al. The nuclear receptor ERRa is required for the bioenergetic and functional adaptation to cardiac pressure overload. Cell Metab. 6, 25-37 (2007).
43. Rickelt, S., Moll, I. & Franke, W.W. Intercellular adhering junctions with an asymmetric molecular composition: desmosomes connecting Merkel cells and keratinocytes. Cell Tissue Res. 346, 65-77 (2011).
44. García-Nogales, P., Almeida, A., Fernandez, E., Medina, J.M. & Bolanos, J.P. Induction of glucose-6-phosphate dehydrogenase by lipopolysaccharide contributes to preventing nitric oxide-mediated glutathione depletion in cultured rat astrocytes. J. Neurochem. 72, 1750-1758 (1999).
45. Edgar, R., Domrachev, M. & Lash, A.E. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 30, 207-210 (2002).
46. Nakamichi, I. et al. Keratin 8 overexpression promotes mouse Mallory body formation. J. Cell Biol. 171, 931-937 (2005).
47. Pfaffl, M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45 (2001).
48. van den Boogaard, M., Wong, L.Y., Christoffels, V.M. & Barnett, P. Acquisition of high quality DNA for massive parallel sequencing by in vivo chromatin immunoprecipitation. Methods Mol. Biol. 977, 53-64 (2013).
49. Kent, W.J. et al. The human genome browser at UCSC. Genome Res. 12, 996-1006 (2002).
50. Myers, R.M. et al. A user's guide to the encyclopedia of DNA elements (ENCODE). PLoS Biol. 9, e1001046 (2011).
51. Rosenbloom, K.R. et al. ENCODE data in the UCSC Genome Browser: year 5 update. Nucleic Acids Res. 41, D56-D63 (2013).
52. Sabo, P.J. et al. Genome-scale mapping of DNase I sensitivity in vivo using tiling DNA microarrays. Nat. Methods 3, 511-518 (2006).
53. Sabo, P.J. et al. Discovery of functional noncoding elements by digital analysis of chromatin structure. Proc. Natl. Acad. Sci. USA 101, 16837-16842 (2004).
54. Antonaki, A. et al. Genomic analysis reveals a novel nuclear factor-B (NF-B)-binding site in Alu-repetitive elements. J. Biol. Chem. 286, 38768-38782 (2011).
55. Kaltezioti, V. et al. Prox1 regulates the notch1-mediated inhibition of neurogenesis. PLoS Biol. 8, e1000565 (2010).